Percutaneous approach for reducing outflow tract obstruction in hypertrophic obstructive cardiomyopathy

Area of Science:

• Cardiology
• Cardiac Surgery
• Interventional Cardiology

Background:

• Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic heart condition characterized by thickening of the heart muscle.
• It affects approximately 1 in 500 individuals worldwide.
• Current treatments for drug-refractory HOCM include surgical myectomy and septal alcohol ablation.

Purpose of the Study:

• To provide an overview of current septal mass reduction techniques for HOCM.
• To discuss the advancements in minimally invasive approaches for outflow tract obstruction in HOCM.
• To explore potential future percutaneous strategies for HOCM treatment.

Main Methods:

• Review of current surgical and interventional therapies for HOCM.
• Discussion of evolving minimally invasive techniques.
• Exploration of novel percutaneous device-based approaches.

Main Results:

• Surgical resection and septal ablation remain primary interventions for HOCM.
• Minimally invasive techniques are increasingly utilized for outflow tract obstruction.
• Percutaneous septal myectomy with novel devices represents a promising future direction.

Conclusions:

• Septal mass reduction is crucial for managing HOCM.
• Minimally invasive and percutaneous approaches offer evolving treatment paradigms.
• Further research into novel devices and techniques is warranted for HOCM management.